{"transactions":[{"id":800737,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":51304,"kind":"person","name":"Grow Brian","position":1,"cik":"0001759142","reported_name":"Grow Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-25T01:29:49.000Z","date":"2025-01-10","kind":"exercise","planned":false,"acquired":false,"shares":958,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":1.24,"expiration_date":"2025-01-12","underlying":"Class A Common Stock","underlying_shares":958},"source":{"system":"sec-edgar","filing":"0002064832-26-000183","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000206483226000183/form4.xml","form_type":"4"}},{"id":800736,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":51304,"kind":"person","name":"Grow Brian","position":1,"cik":"0001759142","reported_name":"Grow Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2026-04-25T01:29:49.000Z","date":"2025-01-10","kind":"exercise","planned":false,"acquired":true,"shares":958,"price":1.24,"value":1187.92,"ownership":{"direct":true},"balance_after":900682,"source":{"system":"sec-edgar","filing":"0002064832-26-000183","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000206483226000183/form4.xml","form_type":"4"}},{"id":848596,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":61499,"kind":"person","name":"Leibowitz Arthur S","position":1,"cik":"0001467329","reported_name":"Leibowitz Arthur S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-03-11T21:45:54.000Z","date":"2026-03-09","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":2.681,"value":13405.0,"ownership":{"direct":true},"balance_after":291014,"source":{"system":"sec-edgar","filing":"0002064832-26-000129","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1467329/000206483226000129/form4.xml","form_type":"4"}},{"id":849008,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":61533,"kind":"person","name":"Driscoll Michael Joseph","position":1,"cik":"0001912097","reported_name":"Driscoll Michael Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-03-11T17:45:41.000Z","date":"2026-03-09","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":2.6688,"value":26688.0,"ownership":{"direct":true},"balance_after":225707,"source":{"system":"sec-edgar","filing":"0002064832-26-000127","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1912097/000206483226000127/form4.xml","form_type":"4"}},{"id":864986,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63133,"kind":"person","name":"Gillheeney Gary S.","position":1,"cik":"0001757373","reported_name":"Gillheeney Gary S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2026-03-03T21:35:44.000Z","date":"2026-02-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":91311,"price":3.84,"value":350634.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4 is being filed as an amendment to the Form 4 originally filed on February 20, 2026, to correct the number of shares reported as acquired upon the vesting and settlement of a performance share award and the number of shares reported as withheld in satisfaction of tax obligations in connection with such award. No other changes have been made to the original filing."}],"balance_after":4232087,"source":{"system":"sec-edgar","filing":"0002064832-26-000091","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000206483226000091/form4a.xml","form_type":"4/A","original_submission_date":"2026-02-20"}},{"id":864985,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63133,"kind":"person","name":"Gillheeney Gary S.","position":1,"cik":"0001757373","reported_name":"Gillheeney Gary S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2026-03-03T21:35:44.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":188856,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4 is being filed as an amendment to the Form 4 originally filed on February 20, 2026, to correct the number of shares reported as acquired upon the vesting and settlement of a performance share award and the number of shares reported as withheld in satisfaction of tax obligations in connection with such award. No other changes have been made to the original filing."}],"balance_after":4323398,"source":{"system":"sec-edgar","filing":"0002064832-26-000091","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000206483226000091/form4a.xml","form_type":"4/A","original_submission_date":"2026-02-20"}},{"id":864984,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":51304,"kind":"person","name":"Grow Brian","position":1,"cik":"0001759142","reported_name":"Grow Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2026-03-03T21:35:31.000Z","date":"2026-02-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":11887,"price":3.84,"value":45646.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4 is being filed as an amendment to the Form 4 originally filed on February 20, 2026, to correct the number of shares reported as acquired upon the vesting and settlement of a performance share award and the number of shares reported as withheld in satisfaction of tax obligations in connection with such award. No other changes have been made to the original filing."}],"balance_after":899724,"source":{"system":"sec-edgar","filing":"0002064832-26-000090","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000206483226000090/form4a.xml","form_type":"4/A","original_submission_date":"2026-02-20"}},{"id":864983,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":51304,"kind":"person","name":"Grow Brian","position":1,"cik":"0001759142","reported_name":"Grow Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2026-03-03T21:35:31.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":48818,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4 is being filed as an amendment to the Form 4 originally filed on February 20, 2026, to correct the number of shares reported as acquired upon the vesting and settlement of a performance share award and the number of shares reported as withheld in satisfaction of tax obligations in connection with such award. No other changes have been made to the original filing."}],"balance_after":911611,"source":{"system":"sec-edgar","filing":"0002064832-26-000090","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000206483226000090/form4a.xml","form_type":"4/A","original_submission_date":"2026-02-20"}},{"id":864982,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63132,"kind":"person","name":"Bilbo Patrick","position":1,"cik":"0001759203","reported_name":"Bilbo Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2026-03-03T21:35:09.000Z","date":"2026-02-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":16375,"price":3.84,"value":62880.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4 is being filed as an amendment to the Form 4 originally filed on February 20, 2026, to correct the number of shares reported as acquired upon the vesting and settlement of a performance share award and the number of shares reported as withheld in satisfaction of tax obligations in connection with such award. No other changes have been made to the original filing."}],"balance_after":1128312,"source":{"system":"sec-edgar","filing":"0002064832-26-000089","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000206483226000089/form4a.xml","form_type":"4/A","original_submission_date":"2026-02-20"}},{"id":864981,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63132,"kind":"person","name":"Bilbo Patrick","position":1,"cik":"0001759203","reported_name":"Bilbo Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2026-03-03T21:35:09.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":49102,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4 is being filed as an amendment to the Form 4 originally filed on February 20, 2026, to correct the number of shares reported as acquired upon the vesting and settlement of a performance share award and the number of shares reported as withheld in satisfaction of tax obligations in connection with such award. No other changes have been made to the original filing."}],"balance_after":1144687,"source":{"system":"sec-edgar","filing":"0002064832-26-000089","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000206483226000089/form4a.xml","form_type":"4/A","original_submission_date":"2026-02-20"}},{"id":864980,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63131,"kind":"person","name":"Francisco David","position":1,"cik":"0001846282","reported_name":"Francisco David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2026-03-03T21:34:58.000Z","date":"2026-02-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":14687,"price":3.84,"value":56398.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4 is being filed as an amendment to the Form 4 originally filed on February 20, 2026, to correct the number of shares reported as acquired upon the vesting and settlement of a performance share award and the number of shares reported as withheld in satisfaction of tax obligations in connection with such award. No other changes have been made to the original filing."}],"balance_after":731312,"source":{"system":"sec-edgar","filing":"0002064832-26-000088","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000206483226000088/form4a.xml","form_type":"4/A","original_submission_date":"2026-02-20"}},{"id":864979,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63131,"kind":"person","name":"Francisco David","position":1,"cik":"0001846282","reported_name":"Francisco David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2026-03-03T21:34:58.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":44040,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4 is being filed as an amendment to the Form 4 originally filed on February 20, 2026, to correct the number of shares reported as acquired upon the vesting and settlement of a performance share award and the number of shares reported as withheld in satisfaction of tax obligations in connection with such award. No other changes have been made to the original filing."}],"balance_after":745999,"source":{"system":"sec-edgar","filing":"0002064832-26-000088","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000206483226000088/form4a.xml","form_type":"4/A","original_submission_date":"2026-02-20"}},{"id":868718,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63419,"kind":"person","name":"Cavorsi Robert","position":1,"cik":"0002020983","reported_name":"Cavorsi Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Strategy"}}],"security":"Class A Common Stock","published_at":"2026-03-03T16:55:55.000Z","date":"2026-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":700,"price":3.21,"value":2247.0,"ownership":{"direct":true},"balance_after":275524,"source":{"system":"sec-edgar","filing":"0002064832-26-000093","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2020983/000206483226000093/form4.xml","form_type":"4"}},{"id":867652,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63338,"kind":"person","name":"Montecalvo Antonio S.","position":1,"cik":"0001759261","reported_name":"Montecalvo Antonio S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Health Policy"}}],"security":"Class A Common Stock","published_at":"2026-03-03T16:35:56.000Z","date":"2026-02-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":3778,"price":3.84,"value":14507.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4 is being filed as an amendment to the Form 4 originally filed on February 20, 2026, to correct the number of shares reported as acquired upon the vesting and settlement of a performance share award and the number of shares reported as withheld in satisfaction of tax obligations in connection with such award. No other changes have been made to the original filing."}],"balance_after":226238,"source":{"system":"sec-edgar","filing":"0002064832-26-000092","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759261/000206483226000092/form4a.xml","form_type":"4/A","original_submission_date":"2026-02-20"}},{"id":867651,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63338,"kind":"person","name":"Montecalvo Antonio S.","position":1,"cik":"0001759261","reported_name":"Montecalvo Antonio S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Health Policy"}}],"security":"Class A Common Stock","published_at":"2026-03-03T16:35:56.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":11330,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4 is being filed as an amendment to the Form 4 originally filed on February 20, 2026, to correct the number of shares reported as acquired upon the vesting and settlement of a performance share award and the number of shares reported as withheld in satisfaction of tax obligations in connection with such award. No other changes have been made to the original filing."}],"balance_after":230016,"source":{"system":"sec-edgar","filing":"0002064832-26-000092","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759261/000206483226000092/form4a.xml","form_type":"4/A","original_submission_date":"2026-02-20"}},{"id":868717,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63419,"kind":"person","name":"Cavorsi Robert","position":1,"cik":"0002020983","reported_name":"Cavorsi Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Strategy"}}],"security":"Class A Common Stock","published_at":"2026-03-03T16:34:28.000Z","date":"2026-02-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":5487,"price":3.84,"value":21070.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4 is being filed as an amendment to the Form 4 originally filed on February 20, 2026, to correct the number of shares reported as acquired upon the vesting and settlement of a performance share award and the number of shares reported as withheld in satisfaction of tax obligations in connection with such award. No other changes have been made to the original filing."}],"balance_after":276224,"source":{"system":"sec-edgar","filing":"0002064832-26-000087","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2020983/000206483226000087/form4a.xml","form_type":"4/A","original_submission_date":"2026-02-20"}},{"id":868716,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63419,"kind":"person","name":"Cavorsi Robert","position":1,"cik":"0002020983","reported_name":"Cavorsi Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Strategy"}}],"security":"Class A Common Stock","published_at":"2026-03-03T16:34:28.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":16454,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4 is being filed as an amendment to the Form 4 originally filed on February 20, 2026, to correct the number of shares reported as acquired upon the vesting and settlement of a performance share award and the number of shares reported as withheld in satisfaction of tax obligations in connection with such award. No other changes have been made to the original filing."}],"balance_after":281711,"source":{"system":"sec-edgar","filing":"0002064832-26-000087","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2020983/000206483226000087/form4a.xml","form_type":"4/A","original_submission_date":"2026-02-20"}},{"id":866336,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63240,"kind":"person","name":"Freedman Lori","position":1,"cik":"0001410291","reported_name":"Freedman Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Admin. and Legal Officer"}}],"security":"Class A Common Stock","published_at":"2026-03-03T16:34:10.000Z","date":"2026-02-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":14411,"price":3.84,"value":55338.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4 is being filed as an amendment to the Form 4 originally filed on February 20, 2026, to correct the number of shares reported as acquired upon the vesting and settlement of a performance share award and the number of shares reported as withheld in satisfaction of tax obligations in connection with such award. No other changes have been made to the original filing."}],"balance_after":1023643,"source":{"system":"sec-edgar","filing":"0002064832-26-000086","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410291/000206483226000086/form4a.xml","form_type":"4/A","original_submission_date":"2026-02-20"}},{"id":866335,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63240,"kind":"person","name":"Freedman Lori","position":1,"cik":"0001410291","reported_name":"Freedman Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Admin. and Legal Officer"}}],"security":"Class A Common Stock","published_at":"2026-03-03T16:34:10.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":43212,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4 is being filed as an amendment to the Form 4 originally filed on February 20, 2026, to correct the number of shares reported as acquired upon the vesting and settlement of a performance share award and the number of shares reported as withheld in satisfaction of tax obligations in connection with such award. No other changes have been made to the original filing."}],"balance_after":1038054,"source":{"system":"sec-edgar","filing":"0002064832-26-000086","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410291/000206483226000086/form4a.xml","form_type":"4/A","original_submission_date":"2026-02-20"}},{"id":890190,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63131,"kind":"person","name":"Francisco David","position":1,"cik":"0001846282","reported_name":"Francisco David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-20T22:28:38.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":111358,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option becomes exercisable in equal annual installments over four years beginning February 15, 2026."}],"balance_after":111358,"derivative":{"exercise_price":3.84,"expiration_date":"2036-02-18","underlying":"Class A Common Stock","underlying_shares":111358},"source":{"system":"sec-edgar","filing":"0002064832-26-000060","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000206483226000060/form4.xml","form_type":"4"}},{"id":890189,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63131,"kind":"person","name":"Francisco David","position":1,"cik":"0001846282","reported_name":"Francisco David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-20T22:28:38.000Z","date":"2026-02-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":14541,"price":3.84,"value":55837.44,"ownership":{"direct":true},"balance_after":731020,"source":{"system":"sec-edgar","filing":"0002064832-26-000060","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000206483226000060/form4.xml","form_type":"4"}},{"id":890188,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63131,"kind":"person","name":"Francisco David","position":1,"cik":"0001846282","reported_name":"Francisco David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-20T22:28:38.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":43602,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares issued pursuant to the vesting and settlement of a performance share award granted in 2025 based on the achievement of certain performance milestones."}],"balance_after":745561,"source":{"system":"sec-edgar","filing":"0002064832-26-000060","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000206483226000060/form4.xml","form_type":"4"}},{"id":890187,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63131,"kind":"person","name":"Francisco David","position":1,"cik":"0001846282","reported_name":"Francisco David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-20T22:28:38.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":195312,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\") under the Organogenesis Holdings Inc. (\"Organogenesis\") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in equal annual installments over four years beginning February 15, 2026."}],"balance_after":701959,"source":{"system":"sec-edgar","filing":"0002064832-26-000060","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000206483226000060/form4.xml","form_type":"4"}},{"id":890182,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":51304,"kind":"person","name":"Grow Brian","position":1,"cik":"0001759142","reported_name":"Grow Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-20T22:28:21.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":133630,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option becomes exercisable in equal annual installments over four years beginning February 15, 2026."}],"balance_after":133630,"derivative":{"exercise_price":3.84,"expiration_date":"2036-02-18","underlying":"Class A Common Stock","underlying_shares":133630},"source":{"system":"sec-edgar","filing":"0002064832-26-000059","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000206483226000059/form4.xml","form_type":"4"}},{"id":890181,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":51304,"kind":"person","name":"Grow Brian","position":1,"cik":"0001759142","reported_name":"Grow Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-20T22:28:21.000Z","date":"2026-02-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":11768,"price":3.84,"value":45189.12,"ownership":{"direct":true},"balance_after":899355,"source":{"system":"sec-edgar","filing":"0002064832-26-000059","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000206483226000059/form4.xml","form_type":"4"}},{"id":890180,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":51304,"kind":"person","name":"Grow Brian","position":1,"cik":"0001759142","reported_name":"Grow Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-20T22:28:21.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":48330,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares issued pursuant to the vesting and settlement of a performance share award granted in 2025 based on the achievement of certain performance milestones."}],"balance_after":911123,"source":{"system":"sec-edgar","filing":"0002064832-26-000059","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000206483226000059/form4.xml","form_type":"4"}},{"id":890179,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":51304,"kind":"person","name":"Grow Brian","position":1,"cik":"0001759142","reported_name":"Grow Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-20T22:28:21.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":234375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\") under the Organogenesis Holdings Inc. (\"Organogenesis\") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in equal annual installments over four years beginning February 15, 2026."}],"balance_after":862793,"source":{"system":"sec-edgar","filing":"0002064832-26-000059","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000206483226000059/form4.xml","form_type":"4"}},{"id":890186,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63132,"kind":"person","name":"Bilbo Patrick","position":1,"cik":"0001759203","reported_name":"Bilbo Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-20T22:28:06.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":120267,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option becomes exercisable in equal annual installments over four years beginning February 15, 2026."}],"balance_after":120267,"derivative":{"exercise_price":3.84,"expiration_date":"2036-02-18","underlying":"Class A Common Stock","underlying_shares":120267},"source":{"system":"sec-edgar","filing":"0002064832-26-000058","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000206483226000058/form4.xml","form_type":"4"}},{"id":890185,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63132,"kind":"person","name":"Bilbo Patrick","position":1,"cik":"0001759203","reported_name":"Bilbo Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-20T22:28:06.000Z","date":"2026-02-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":16212,"price":3.84,"value":62254.08,"ownership":{"direct":true},"balance_after":1127985,"source":{"system":"sec-edgar","filing":"0002064832-26-000058","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000206483226000058/form4.xml","form_type":"4"}},{"id":890184,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63132,"kind":"person","name":"Bilbo Patrick","position":1,"cik":"0001759203","reported_name":"Bilbo Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-20T22:28:06.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":48612,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares issued pursuant to the vesting and settlement of a performance share award granted in 2025 based on the achievement of certain performance milestones."}],"balance_after":1144197,"source":{"system":"sec-edgar","filing":"0002064832-26-000058","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000206483226000058/form4.xml","form_type":"4"}},{"id":890183,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63132,"kind":"person","name":"Bilbo Patrick","position":1,"cik":"0001759203","reported_name":"Bilbo Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-20T22:28:06.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":210937,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\") under the Organogenesis Holdings Inc. (\"Organogenesis\") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in equal annual installments over four years beginning February 15, 2026."}],"balance_after":1095585,"source":{"system":"sec-edgar","filing":"0002064832-26-000058","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000206483226000058/form4.xml","form_type":"4"}},{"id":890178,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63133,"kind":"person","name":"Gillheeney Gary S.","position":1,"cik":"0001757373","reported_name":"Gillheeney Gary S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-20T22:27:50.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":507795,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option becomes exercisable in equal annual installments over four years beginning February 15, 2026."}],"balance_after":507795,"derivative":{"exercise_price":3.84,"expiration_date":"2036-02-18","underlying":"Class A Common Stock","underlying_shares":507795},"source":{"system":"sec-edgar","filing":"0002064832-26-000057","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000206483226000057/form4.xml","form_type":"4"}},{"id":890177,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63133,"kind":"person","name":"Gillheeney Gary S.","position":1,"cik":"0001757373","reported_name":"Gillheeney Gary S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2026-02-20T22:27:50.000Z","date":"2026-02-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":90398,"price":3.84,"value":347128.32,"ownership":{"direct":true},"balance_after":4231112,"source":{"system":"sec-edgar","filing":"0002064832-26-000057","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000206483226000057/form4.xml","form_type":"4"}},{"id":890176,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63133,"kind":"person","name":"Gillheeney Gary S.","position":1,"cik":"0001757373","reported_name":"Gillheeney Gary S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2026-02-20T22:27:50.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":186968,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares issued pursuant to the vesting and settlement of a performance share award granted in 2025 based on the achievement of certain performance milestones."}],"balance_after":4321510,"source":{"system":"sec-edgar","filing":"0002064832-26-000057","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000206483226000057/form4.xml","form_type":"4"}},{"id":890175,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63133,"kind":"person","name":"Gillheeney Gary S.","position":1,"cik":"0001757373","reported_name":"Gillheeney Gary S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2026-02-20T22:27:50.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":890625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\") under the Organogenesis Holdings Inc. (\"Organogenesis\") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in equal annual installments over four years beginning February 15, 2026."}],"balance_after":4134542,"source":{"system":"sec-edgar","filing":"0002064832-26-000057","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000206483226000057/form4.xml","form_type":"4"}},{"id":890174,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":65374,"kind":"person","name":"Quintero Gilberto","position":1,"cik":"0001927023","reported_name":"Quintero Gilberto","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-20T22:26:30.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":48828,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\") under the Organogenesis Holdings Inc. (\"Organogenesis\") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in full on February 15, 2027."}],"balance_after":239073,"source":{"system":"sec-edgar","filing":"0002064832-26-000052","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000206483226000052/form4.xml","form_type":"4"}},{"id":890173,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":65373,"kind":"person","name":"Duraibabu Prathyusha","position":1,"cik":"0001779092","reported_name":"Duraibabu Prathyusha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-20T22:26:16.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":48828,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\") under the Organogenesis Holdings Inc. (\"Organogenesis\") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in full on February 15, 2027."}],"balance_after":247047,"source":{"system":"sec-edgar","filing":"0002064832-26-000051","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000206483226000051/form4.xml","form_type":"4"}},{"id":890172,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":65372,"kind":"person","name":"Korfin Michele Ilene","position":1,"cik":"0001771664","reported_name":"Korfin Michele Ilene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-20T22:25:42.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":48828,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\") under the Organogenesis Holdings Inc. (\"Organogenesis\") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in full on February 15, 2027."}],"balance_after":239073,"source":{"system":"sec-edgar","filing":"0002064832-26-000049","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000206483226000049/form4.xml","form_type":"4"}},{"id":890542,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63240,"kind":"person","name":"Freedman Lori","position":1,"cik":"0001410291","reported_name":"Freedman Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Admin. and Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-20T17:29:07.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":115812,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option becomes exercisable in equal annual installments over four years beginning February 15, 2026."}],"balance_after":115812,"derivative":{"exercise_price":3.84,"expiration_date":"2036-02-18","underlying":"Class A Common Stock","underlying_shares":115812},"source":{"system":"sec-edgar","filing":"0002064832-26-000062","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1410291/000206483226000062/form4.xml","form_type":"4"}},{"id":890541,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63240,"kind":"person","name":"Freedman Lori","position":1,"cik":"0001410291","reported_name":"Freedman Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Admin. and Legal Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-20T17:29:07.000Z","date":"2026-02-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":14267,"price":3.84,"value":54785.28,"ownership":{"direct":true},"balance_after":1023355,"source":{"system":"sec-edgar","filing":"0002064832-26-000062","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1410291/000206483226000062/form4.xml","form_type":"4"}},{"id":890540,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63240,"kind":"person","name":"Freedman Lori","position":1,"cik":"0001410291","reported_name":"Freedman Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Admin. and Legal Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-20T17:29:07.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":42780,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares issued pursuant to the vesting and settlement of a performance share award granted in 2025 based on the achievement of certain performance milestones."}],"balance_after":1037622,"source":{"system":"sec-edgar","filing":"0002064832-26-000062","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410291/000206483226000062/form4.xml","form_type":"4"}},{"id":890539,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63240,"kind":"person","name":"Freedman Lori","position":1,"cik":"0001410291","reported_name":"Freedman Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Admin. and Legal Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-20T17:29:07.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":203125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\") under the Organogenesis Holdings Inc. (\"Organogenesis\") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in equal annual installments over four years beginning February 15, 2026."}],"balance_after":994842,"source":{"system":"sec-edgar","filing":"0002064832-26-000062","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410291/000206483226000062/form4.xml","form_type":"4"}},{"id":890994,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63419,"kind":"person","name":"Cavorsi Robert","position":1,"cik":"0002020983","reported_name":"Cavorsi Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Strategy"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-20T17:28:53.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":53452,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option becomes exercisable in equal annual installments over four years beginning February 15, 2026."}],"balance_after":53452,"derivative":{"exercise_price":3.84,"expiration_date":"2036-02-18","underlying":"Class A Common Stock","underlying_shares":53452},"source":{"system":"sec-edgar","filing":"0002064832-26-000061","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2020983/000206483226000061/form4.xml","form_type":"4"}},{"id":890993,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63419,"kind":"person","name":"Cavorsi Robert","position":1,"cik":"0002020983","reported_name":"Cavorsi Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Strategy"}}],"security":"Class A Common Stock","published_at":"2026-02-20T17:28:53.000Z","date":"2026-02-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":5432,"price":3.84,"value":20858.88,"ownership":{"direct":true},"balance_after":276115,"source":{"system":"sec-edgar","filing":"0002064832-26-000061","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2020983/000206483226000061/form4.xml","form_type":"4"}},{"id":890992,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63419,"kind":"person","name":"Cavorsi Robert","position":1,"cik":"0002020983","reported_name":"Cavorsi Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Strategy"}}],"security":"Class A Common Stock","published_at":"2026-02-20T17:28:53.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":16290,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares issued pursuant to the vesting and settlement of a performance share award granted in 2025 based on the achievement of certain performance milestones."}],"balance_after":281547,"source":{"system":"sec-edgar","filing":"0002064832-26-000061","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2020983/000206483226000061/form4.xml","form_type":"4"}},{"id":890991,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63419,"kind":"person","name":"Cavorsi Robert","position":1,"cik":"0002020983","reported_name":"Cavorsi Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Strategy"}}],"security":"Class A Common Stock","published_at":"2026-02-20T17:28:53.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":93750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\") under the Organogenesis Holdings Inc. (\"Organogenesis\") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in equal annual installments over four years beginning February 15, 2026."}],"balance_after":265257,"source":{"system":"sec-edgar","filing":"0002064832-26-000061","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2020983/000206483226000061/form4.xml","form_type":"4"}},{"id":890939,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":61533,"kind":"person","name":"Driscoll Michael Joseph","position":1,"cik":"0001912097","reported_name":"Driscoll Michael Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-20T17:27:36.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":48828,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\") under the Organogenesis Holdings Inc. (\"Organogenesis\") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in full on February 15, 2027."}],"balance_after":215707,"source":{"system":"sec-edgar","filing":"0002064832-26-000056","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1912097/000206483226000056/form4.xml","form_type":"4"}},{"id":890206,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":65376,"kind":"person","name":"Giacomin Jon L","position":1,"cik":"0001623254","reported_name":"Giacomin Jon L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-20T17:27:18.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":48828,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\") under the Organogenesis Holdings Inc. (\"Organogenesis\") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in full on February 15, 2027."}],"balance_after":241026,"source":{"system":"sec-edgar","filing":"0002064832-26-000055","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623254/000206483226000055/form4.xml","form_type":"4"}},{"id":890570,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":61499,"kind":"person","name":"Leibowitz Arthur S","position":1,"cik":"0001467329","reported_name":"Leibowitz Arthur S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-20T17:27:03.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":48828,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\") under the Organogenesis Holdings Inc. (\"Organogenesis\") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in full on February 15, 2027."}],"balance_after":286014,"source":{"system":"sec-edgar","filing":"0002064832-26-000054","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1467329/000206483226000054/form4.xml","form_type":"4"}},{"id":890763,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63338,"kind":"person","name":"Montecalvo Antonio S.","position":1,"cik":"0001759261","reported_name":"Montecalvo Antonio S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Health Policy"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-20T17:26:48.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":23162,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option becomes exercisable in equal annual installments over four years beginning February 15, 2026."}],"balance_after":23162,"derivative":{"exercise_price":3.84,"expiration_date":"2036-02-18","underlying":"Class A Common Stock","underlying_shares":23162},"source":{"system":"sec-edgar","filing":"0002064832-26-000053","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1759261/000206483226000053/form4.xml","form_type":"4"}},{"id":890762,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63338,"kind":"person","name":"Montecalvo Antonio S.","position":1,"cik":"0001759261","reported_name":"Montecalvo Antonio S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Health Policy"}}],"security":"Class A Common Stock","published_at":"2026-02-20T17:26:48.000Z","date":"2026-02-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":3741,"price":3.84,"value":14365.44,"ownership":{"direct":true},"balance_after":226163,"source":{"system":"sec-edgar","filing":"0002064832-26-000053","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1759261/000206483226000053/form4.xml","form_type":"4"}},{"id":890761,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63338,"kind":"person","name":"Montecalvo Antonio S.","position":1,"cik":"0001759261","reported_name":"Montecalvo Antonio S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Health Policy"}}],"security":"Class A Common Stock","published_at":"2026-02-20T17:26:48.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":11218,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares issued pursuant to the vesting and settlement of a performance share award granted in 2025 based on the achievement of certain performance milestones."}],"balance_after":229904,"source":{"system":"sec-edgar","filing":"0002064832-26-000053","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759261/000206483226000053/form4.xml","form_type":"4"}},{"id":890760,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63338,"kind":"person","name":"Montecalvo Antonio S.","position":1,"cik":"0001759261","reported_name":"Montecalvo Antonio S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Health Policy"}}],"security":"Class A Common Stock","published_at":"2026-02-20T17:26:48.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":40625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\") under the Organogenesis Holdings Inc. (\"Organogenesis\") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in equal annual installments over four years beginning February 15, 2026."}],"balance_after":218686,"source":{"system":"sec-edgar","filing":"0002064832-26-000053","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759261/000206483226000053/form4.xml","form_type":"4"}},{"id":891041,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":65468,"kind":"person","name":"Lustig Garrett","position":1,"cik":"0002044364","reported_name":"Lustig Garrett","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-20T17:26:02.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":48828,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\") under the Organogenesis Holdings Inc. (\"Organogenesis\") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in full on February 15, 2027."}],"balance_after":125742,"source":{"system":"sec-edgar","filing":"0002064832-26-000050","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2044364/000206483226000050/form4.xml","form_type":"4"}},{"id":895679,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63131,"kind":"person","name":"Francisco David","position":1,"cik":"0001846282","reported_name":"Francisco David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-18T21:37:45.000Z","date":"2026-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":13769,"price":3.73,"value":51358.37,"ownership":{"direct":true},"balance_after":506647,"source":{"system":"sec-edgar","filing":"0002064832-26-000031","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000206483226000031/form4.xml","form_type":"4"}},{"id":895678,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63131,"kind":"person","name":"Francisco David","position":1,"cik":"0001846282","reported_name":"Francisco David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-18T21:37:45.000Z","date":"2026-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":13369,"price":3.73,"value":49866.37,"ownership":{"direct":true},"balance_after":520416,"source":{"system":"sec-edgar","filing":"0002064832-26-000031","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000206483226000031/form4.xml","form_type":"4"}},{"id":895677,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63131,"kind":"person","name":"Francisco David","position":1,"cik":"0001846282","reported_name":"Francisco David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-18T21:37:45.000Z","date":"2026-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":21412,"price":3.73,"value":79866.76,"ownership":{"direct":true},"balance_after":533785,"source":{"system":"sec-edgar","filing":"0002064832-26-000031","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000206483226000031/form4.xml","form_type":"4"}},{"id":895676,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63131,"kind":"person","name":"Francisco David","position":1,"cik":"0001846282","reported_name":"Francisco David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-18T21:37:45.000Z","date":"2026-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":3898,"price":3.73,"value":14539.54,"ownership":{"direct":true},"balance_after":555197,"source":{"system":"sec-edgar","filing":"0002064832-26-000031","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000206483226000031/form4.xml","form_type":"4"}},{"id":895675,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63132,"kind":"person","name":"Bilbo Patrick","position":1,"cik":"0001759203","reported_name":"Bilbo Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-18T21:37:32.000Z","date":"2026-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":15352,"price":3.73,"value":57262.96,"ownership":{"direct":true},"balance_after":884648,"source":{"system":"sec-edgar","filing":"0002064832-26-000030","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000206483226000030/form4.xml","form_type":"4"}},{"id":895674,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63132,"kind":"person","name":"Bilbo Patrick","position":1,"cik":"0001759203","reported_name":"Bilbo Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-18T21:37:32.000Z","date":"2026-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":15617,"price":3.73,"value":58251.41,"ownership":{"direct":true},"balance_after":900000,"source":{"system":"sec-edgar","filing":"0002064832-26-000030","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000206483226000030/form4.xml","form_type":"4"}},{"id":895673,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63132,"kind":"person","name":"Bilbo Patrick","position":1,"cik":"0001759203","reported_name":"Bilbo Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-18T21:37:32.000Z","date":"2026-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":28331,"price":3.73,"value":105674.63,"ownership":{"direct":true},"balance_after":915617,"source":{"system":"sec-edgar","filing":"0002064832-26-000030","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000206483226000030/form4.xml","form_type":"4"}},{"id":895672,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63132,"kind":"person","name":"Bilbo Patrick","position":1,"cik":"0001759203","reported_name":"Bilbo Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-18T21:37:32.000Z","date":"2026-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":5114,"price":3.73,"value":19075.22,"ownership":{"direct":true},"balance_after":943948,"source":{"system":"sec-edgar","filing":"0002064832-26-000030","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000206483226000030/form4.xml","form_type":"4"}},{"id":895671,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63133,"kind":"person","name":"Gillheeney Gary S.","position":1,"cik":"0001757373","reported_name":"Gillheeney Gary S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2026-02-18T21:36:45.000Z","date":"2026-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":85605,"price":3.73,"value":319306.65,"ownership":{"direct":true},"balance_after":3243917,"source":{"system":"sec-edgar","filing":"0002064832-26-000027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000206483226000027/form4.xml","form_type":"4"}},{"id":895670,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63133,"kind":"person","name":"Gillheeney Gary S.","position":1,"cik":"0001757373","reported_name":"Gillheeney Gary S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2026-02-18T21:36:45.000Z","date":"2026-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":82815,"price":3.73,"value":308899.95,"ownership":{"direct":true},"balance_after":3329522,"source":{"system":"sec-edgar","filing":"0002064832-26-000027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000206483226000027/form4.xml","form_type":"4"}},{"id":895669,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63133,"kind":"person","name":"Gillheeney Gary S.","position":1,"cik":"0001757373","reported_name":"Gillheeney Gary S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2026-02-18T21:36:45.000Z","date":"2026-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":78646,"price":3.73,"value":293349.58,"ownership":{"direct":true},"balance_after":3412337,"source":{"system":"sec-edgar","filing":"0002064832-26-000027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000206483226000027/form4.xml","form_type":"4"}},{"id":895668,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63133,"kind":"person","name":"Gillheeney Gary S.","position":1,"cik":"0001757373","reported_name":"Gillheeney Gary S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2026-02-18T21:36:45.000Z","date":"2026-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":24340,"price":3.73,"value":90788.2,"ownership":{"direct":true},"balance_after":3490983,"source":{"system":"sec-edgar","filing":"0002064832-26-000027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000206483226000027/form4.xml","form_type":"4"}},{"id":895667,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":51304,"kind":"person","name":"Grow Brian","position":1,"cik":"0001759142","reported_name":"Grow Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-18T21:36:32.000Z","date":"2026-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":11144,"price":3.73,"value":41567.12,"ownership":{"direct":true},"balance_after":628418,"source":{"system":"sec-edgar","filing":"0002064832-26-000026","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000206483226000026/form4.xml","form_type":"4"}},{"id":895666,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":51304,"kind":"person","name":"Grow Brian","position":1,"cik":"0001759142","reported_name":"Grow Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-18T21:36:32.000Z","date":"2026-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":10559,"price":3.73,"value":39385.07,"ownership":{"direct":true},"balance_after":639562,"source":{"system":"sec-edgar","filing":"0002064832-26-000026","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000206483226000026/form4.xml","form_type":"4"}},{"id":895665,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":51304,"kind":"person","name":"Grow Brian","position":1,"cik":"0001759142","reported_name":"Grow Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-18T21:36:32.000Z","date":"2026-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":18910,"price":3.73,"value":70534.3,"ownership":{"direct":true},"balance_after":650121,"source":{"system":"sec-edgar","filing":"0002064832-26-000026","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000206483226000026/form4.xml","form_type":"4"}},{"id":895664,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":51304,"kind":"person","name":"Grow Brian","position":1,"cik":"0001759142","reported_name":"Grow Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-18T21:36:32.000Z","date":"2026-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":3346,"price":3.73,"value":12480.58,"ownership":{"direct":true},"balance_after":669031,"source":{"system":"sec-edgar","filing":"0002064832-26-000026","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000206483226000026/form4.xml","form_type":"4"}},{"id":897436,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63419,"kind":"person","name":"Cavorsi Robert","position":1,"cik":"0002020983","reported_name":"Cavorsi Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Strategy"}}],"security":"Class A Common Stock","published_at":"2026-02-18T16:37:16.000Z","date":"2026-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":5442,"price":3.73,"value":20298.66,"ownership":{"direct":true},"balance_after":171507,"source":{"system":"sec-edgar","filing":"0002064832-26-000029","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2020983/000206483226000029/form4.xml","form_type":"4"}},{"id":897435,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63419,"kind":"person","name":"Cavorsi Robert","position":1,"cik":"0002020983","reported_name":"Cavorsi Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Strategy"}}],"security":"Class A Common Stock","published_at":"2026-02-18T16:37:16.000Z","date":"2026-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":5549,"price":3.73,"value":20697.77,"ownership":{"direct":true},"balance_after":176949,"source":{"system":"sec-edgar","filing":"0002064832-26-000029","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2020983/000206483226000029/form4.xml","form_type":"4"}},{"id":897434,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63419,"kind":"person","name":"Cavorsi Robert","position":1,"cik":"0002020983","reported_name":"Cavorsi Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Strategy"}}],"security":"Class A Common Stock","published_at":"2026-02-18T16:37:16.000Z","date":"2026-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":6667,"price":3.73,"value":24867.91,"ownership":{"direct":true},"balance_after":182498,"source":{"system":"sec-edgar","filing":"0002064832-26-000029","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2020983/000206483226000029/form4.xml","form_type":"4"}},{"id":896533,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63240,"kind":"person","name":"Freedman Lori","position":1,"cik":"0001410291","reported_name":"Freedman Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Admin. and Legal Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-18T16:37:02.000Z","date":"2026-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":13510,"price":3.73,"value":50392.3,"ownership":{"direct":true},"balance_after":791717,"source":{"system":"sec-edgar","filing":"0002064832-26-000028","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1410291/000206483226000028/form4.xml","form_type":"4"}},{"id":896532,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63240,"kind":"person","name":"Freedman Lori","position":1,"cik":"0001410291","reported_name":"Freedman Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Admin. and Legal Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-18T16:37:02.000Z","date":"2026-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":12761,"price":3.73,"value":47598.53,"ownership":{"direct":true},"balance_after":805227,"source":{"system":"sec-edgar","filing":"0002064832-26-000028","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1410291/000206483226000028/form4.xml","form_type":"4"}},{"id":896531,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63240,"kind":"person","name":"Freedman Lori","position":1,"cik":"0001410291","reported_name":"Freedman Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Admin. and Legal Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-18T16:37:02.000Z","date":"2026-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":24428,"price":3.73,"value":91116.44,"ownership":{"direct":true},"balance_after":817988,"source":{"system":"sec-edgar","filing":"0002064832-26-000028","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410291/000206483226000028/form4.xml","form_type":"4"}},{"id":896530,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63240,"kind":"person","name":"Freedman Lori","position":1,"cik":"0001410291","reported_name":"Freedman Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Admin. and Legal Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-18T16:37:02.000Z","date":"2026-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":4043,"price":3.73,"value":15080.39,"ownership":{"direct":true},"balance_after":842416,"source":{"system":"sec-edgar","filing":"0002064832-26-000028","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410291/000206483226000028/form4.xml","form_type":"4"}},{"id":896987,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63338,"kind":"person","name":"Montecalvo Antonio S.","position":1,"cik":"0001759261","reported_name":"Montecalvo Antonio S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Health Policy"}}],"security":"Class A Common Stock","published_at":"2026-02-18T16:36:17.000Z","date":"2026-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":3523,"price":3.73,"value":13140.79,"ownership":{"direct":true},"balance_after":178061,"source":{"system":"sec-edgar","filing":"0002064832-26-000025","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1759261/000206483226000025/form4.xml","form_type":"4"}},{"id":896986,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63338,"kind":"person","name":"Montecalvo Antonio S.","position":1,"cik":"0001759261","reported_name":"Montecalvo Antonio S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Health Policy"}}],"security":"Class A Common Stock","published_at":"2026-02-18T16:36:17.000Z","date":"2026-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":4100,"price":3.73,"value":15293.0,"ownership":{"direct":true},"balance_after":181584,"source":{"system":"sec-edgar","filing":"0002064832-26-000025","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1759261/000206483226000025/form4.xml","form_type":"4"}},{"id":896985,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63338,"kind":"person","name":"Montecalvo Antonio S.","position":1,"cik":"0001759261","reported_name":"Montecalvo Antonio S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Health Policy"}}],"security":"Class A Common Stock","published_at":"2026-02-18T16:36:17.000Z","date":"2026-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":9607,"price":3.73,"value":35834.11,"ownership":{"direct":true},"balance_after":185684,"source":{"system":"sec-edgar","filing":"0002064832-26-000025","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759261/000206483226000025/form4.xml","form_type":"4"}},{"id":896984,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63338,"kind":"person","name":"Montecalvo Antonio S.","position":1,"cik":"0001759261","reported_name":"Montecalvo Antonio S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Health Policy"}}],"security":"Class A Common Stock","published_at":"2026-02-18T16:36:17.000Z","date":"2026-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":1389,"price":3.73,"value":5180.97,"ownership":{"direct":true},"balance_after":195291,"source":{"system":"sec-edgar","filing":"0002064832-26-000025","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759261/000206483226000025/form4.xml","form_type":"4"}},{"id":962998,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":71184,"kind":"person","name":"NUSSDORF GLENN H","position":1,"cik":"0001244191","reported_name":"NUSSDORF GLENN H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-12-18T16:19:19.000Z","date":"2025-12-16","kind":"sale","planned":false,"acquired":false,"shares":200000,"price":5.1353,"value":1027060.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $5.10 to $5.24, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4."}],"balance_after":2565591,"source":{"system":"sec-edgar","filing":"0002064832-25-000090","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1244191/000206483225000090/form4.xml","form_type":"4"}},{"id":986810,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":71184,"kind":"person","name":"NUSSDORF GLENN H","position":1,"cik":"0001244191","reported_name":"NUSSDORF GLENN H","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2025-11-26T18:24:24.000Z","date":"2025-11-26","kind":"sale","planned":false,"acquired":false,"shares":187957,"price":5.29,"value":994292.53,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $5.25 to $5.39, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."}],"balance_after":2765591,"source":{"system":"sec-edgar","filing":"0002064832-25-000040","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1244191/000206483225000040/form4.xml","form_type":"4"}},{"id":986809,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":71184,"kind":"person","name":"NUSSDORF GLENN H","position":1,"cik":"0001244191","reported_name":"NUSSDORF GLENN H","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2025-11-26T18:24:24.000Z","date":"2025-11-25","kind":"sale","planned":false,"acquired":false,"shares":12043,"price":5.3,"value":63827.9,"ownership":{"direct":true},"balance_after":2953548,"source":{"system":"sec-edgar","filing":"0002064832-25-000040","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1244191/000206483225000040/form4.xml","form_type":"4"}},{"id":986808,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":71184,"kind":"person","name":"NUSSDORF GLENN H","position":1,"cik":"0001244191","reported_name":"NUSSDORF GLENN H","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2025-11-26T18:24:24.000Z","date":"2025-11-24","kind":"sale","planned":false,"acquired":false,"shares":100000,"price":5.34,"value":534000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $5.30 to $5.40, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4."}],"balance_after":2965591,"source":{"system":"sec-edgar","filing":"0002064832-25-000040","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1244191/000206483225000040/form4.xml","form_type":"4"}},{"id":1009491,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":71184,"kind":"person","name":"NUSSDORF GLENN H","position":1,"cik":"0001244191","reported_name":"NUSSDORF GLENN H","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2025-11-03T17:25:00.000Z","date":"2025-06-10","kind":"sale","planned":false,"acquired":false,"shares":18620,"price":3.5583,"value":66255.546,"ownership":{"direct":false,"nature":"By Glenn Nussdorf 10 Year Follow On Trust Dated 11-1-1998"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"The reporting person's sale of an aggregate of 22,776 shares of the issuer's Class A common stock on June 9, 2025 and June 10, 2025 reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, with the reporting person's purchase of 22,776 shares of the issuer's Class A common stock on May 15, 2025. The reporting person has paid to the issuer an amount equal to $13,285.24, representing the full amount of the profit realized in connection with the short-swing transaction ($12,971.78) plus interest at the rate of 6% per annum through the date of payment ($313.46)."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $3.55 to $3.59, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4."}],"balance_after":335719,"source":{"system":"sec-edgar","filing":"0002064832-25-000013","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1244191/000206483225000013/form4.xml","form_type":"4"}},{"id":1009490,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":71184,"kind":"person","name":"NUSSDORF GLENN H","position":1,"cik":"0001244191","reported_name":"NUSSDORF GLENN H","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2025-11-03T17:25:00.000Z","date":"2025-06-09","kind":"sale","planned":false,"acquired":false,"shares":4156,"price":3.5003,"value":14547.2468,"ownership":{"direct":false,"nature":"By Glenn Nussdorf 10 Year Follow On Trust Dated 11-1-1998"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"The reporting person's sale of an aggregate of 22,776 shares of the issuer's Class A common stock on June 9, 2025 and June 10, 2025 reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, with the reporting person's purchase of 22,776 shares of the issuer's Class A common stock on May 15, 2025. The reporting person has paid to the issuer an amount equal to $13,285.24, representing the full amount of the profit realized in connection with the short-swing transaction ($12,971.78) plus interest at the rate of 6% per annum through the date of payment ($313.46)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $3.50 to $3.505, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4."}],"balance_after":354339,"source":{"system":"sec-edgar","filing":"0002064832-25-000013","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1244191/000206483225000013/form4.xml","form_type":"4"}},{"id":1009489,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":71184,"kind":"person","name":"NUSSDORF GLENN H","position":1,"cik":"0001244191","reported_name":"NUSSDORF GLENN H","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2025-11-03T17:25:00.000Z","date":"2025-05-15","kind":"purchase","planned":false,"acquired":true,"shares":107494,"price":2.9862,"value":320998.5828,"ownership":{"direct":false,"nature":"By Glenn Nussdorf 10 Year Follow On Trust Dated 11-1-1998"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $2.9725 to $3.00, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (2) to this Form 4."}],"balance_after":358495,"source":{"system":"sec-edgar","filing":"0002064832-25-000013","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1244191/000206483225000013/form4.xml","form_type":"4"}},{"id":1009488,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":71184,"kind":"person","name":"NUSSDORF GLENN H","position":1,"cik":"0001244191","reported_name":"NUSSDORF GLENN H","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2025-11-03T17:25:00.000Z","date":"2025-05-14","kind":"purchase","planned":false,"acquired":true,"shares":251001,"price":3.0878,"value":775040.8878,"ownership":{"direct":false,"nature":"By Glenn Nussdorf 10 Year Follow On Trust Dated 11-1-1998"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $3.00 to $3.10, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4."}],"balance_after":251001,"source":{"system":"sec-edgar","filing":"0002064832-25-000013","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1244191/000206483225000013/form4.xml","form_type":"4"}},{"id":1067494,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":51304,"kind":"person","name":"Grow Brian","position":1,"cik":"0001759142","reported_name":"Grow Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-13T20:08:38.000Z","date":"2025-08-11","kind":"exercise","planned":false,"acquired":false,"shares":4060,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":2.47,"expiration_date":"2025-08-11","underlying":"Class A Common Stock","underlying_shares":4060},"source":{"system":"sec-edgar","filing":"0001062993-25-014296","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000106299325014296/form4.xml","form_type":"4"}},{"id":1067493,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":51304,"kind":"person","name":"Grow Brian","position":1,"cik":"0001759142","reported_name":"Grow Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2025-08-13T20:08:38.000Z","date":"2025-08-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":2173,"price":4.615,"value":10028.395,"ownership":{"direct":true},"balance_after":672377,"source":{"system":"sec-edgar","filing":"0001062993-25-014296","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000106299325014296/form4.xml","form_type":"4"}},{"id":1067492,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":51304,"kind":"person","name":"Grow Brian","position":1,"cik":"0001759142","reported_name":"Grow Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2025-08-13T20:08:38.000Z","date":"2025-08-11","kind":"exercise","planned":false,"acquired":true,"shares":4060,"price":2.47,"value":10028.2,"ownership":{"direct":true},"balance_after":674550,"source":{"system":"sec-edgar","filing":"0001062993-25-014296","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000106299325014296/form4.xml","form_type":"4"}},{"id":1084803,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63419,"kind":"person","name":"Cavorsi Robert","position":1,"cik":"0002020983","reported_name":"Cavorsi Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Strategy"}}],"security":"Class A Common Stock","published_at":"2025-07-18T16:13:38.000Z","date":"2025-07-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":360,"price":4.465,"value":1607.4,"ownership":{"direct":true},"balance_after":189165,"source":{"system":"sec-edgar","filing":"0001062993-25-012995","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2020983/000106299325012995/form4.xml","form_type":"4"}},{"id":1119443,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63240,"kind":"person","name":"Freedman Lori","position":1,"cik":"0001410291","reported_name":"Freedman Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Admin. and Legal Officer"}}],"security":"Class A Common Stock","published_at":"2025-06-06T17:44:18.000Z","date":"2025-06-06","kind":"purchase","planned":false,"acquired":true,"shares":9022,"price":2.987,"value":26948.714,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $2.945 to $3.00, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (3) to this Form 4."}],"balance_after":846459,"source":{"system":"sec-edgar","filing":"0001062993-25-011161","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1410291/000106299325011161/form4.xml","form_type":"4"}},{"id":1119442,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63240,"kind":"person","name":"Freedman Lori","position":1,"cik":"0001410291","reported_name":"Freedman Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Admin. and Legal Officer"}}],"security":"Class A Common Stock","published_at":"2025-06-06T17:44:18.000Z","date":"2025-06-05","kind":"purchase","planned":false,"acquired":true,"shares":142379,"price":2.9051,"value":413625.2329,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $2.815 to $2.98, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (2) to this Form 4."}],"balance_after":837437,"source":{"system":"sec-edgar","filing":"0001062993-25-011161","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410291/000106299325011161/form4.xml","form_type":"4"}},{"id":1119441,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63240,"kind":"person","name":"Freedman Lori","position":1,"cik":"0001410291","reported_name":"Freedman Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Admin. and Legal Officer"}}],"security":"Class A Common Stock","published_at":"2025-06-06T17:44:18.000Z","date":"2025-06-04","kind":"purchase","planned":false,"acquired":true,"shares":100863,"price":2.8228,"value":284716.0764,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $2.74 to $2.875, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4."}],"balance_after":695058,"source":{"system":"sec-edgar","filing":"0001062993-25-011161","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410291/000106299325011161/form4.xml","form_type":"4"}},{"id":1210180,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63419,"kind":"person","name":"Cavorsi Robert","position":1,"cik":"0002020983","reported_name":"Cavorsi Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Strategy"}}],"security":"Class A Common Stock","published_at":"2025-03-12T16:29:29.000Z","date":"2025-03-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":61,"price":5.16,"value":314.76,"ownership":{"direct":true},"balance_after":189525,"source":{"system":"sec-edgar","filing":"0001062993-25-005250","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2020983/000106299325005250/form4.xml","form_type":"4"}},{"id":1210179,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63419,"kind":"person","name":"Cavorsi Robert","position":1,"cik":"0002020983","reported_name":"Cavorsi Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Strategy"}}],"security":"Class A Common Stock","published_at":"2025-03-12T16:29:29.000Z","date":"2025-03-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":210,"price":5.16,"value":1083.6,"ownership":{"direct":true},"balance_after":189586,"source":{"system":"sec-edgar","filing":"0001062993-25-005250","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2020983/000106299325005250/form4.xml","form_type":"4"}},{"id":1219914,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":61533,"kind":"person","name":"Driscoll Michael Joseph","position":1,"cik":"0001912097","reported_name":"Driscoll Michael Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-03-06T21:08:33.000Z","date":"2025-03-04","kind":"sale","planned":false,"acquired":false,"shares":25000,"price":5.1014,"value":127535.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $5.00 to $5.33, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4."}],"balance_after":166879,"source":{"system":"sec-edgar","filing":"0001062993-25-004849","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1912097/000106299325004849/form4.xml","form_type":"4"}},{"id":1229989,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63419,"kind":"person","name":"Cavorsi Robert","position":1,"cik":"0002020983","reported_name":"Cavorsi Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Strategy"}}],"security":"Class A Common Stock","published_at":"2025-03-04T17:01:25.000Z","date":"2025-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":667,"price":6.21,"value":4142.07,"ownership":{"direct":true},"balance_after":189796,"source":{"system":"sec-edgar","filing":"0001062993-25-004351","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2020983/000106299325004351/form4.xml","form_type":"4"}}],"next_cursor":"2025-03-04T17:01:25.000000Z,1229989"}